跳至主要内容
临床试验/NCT04135482
NCT04135482已完成不适用

Evaluating the Immune Status of Patients With Severe Crohn's Disease Using Single Cell Sequencing

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
single cell analysis of the colonic tissue of patients with severe crohn's disease

研究概览

简要总结

Using single cell sequencing method to evaluate and compare the immune status of patients with severe CD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1, Patients with severe CD(CDAI>16,SES-CD>19) 2, Patients have no previous any drug therapy targeting CD or just received treatment of 5-ASA -

排除标准

  • 1, patients have previous treatment of prednisone, immunosuppressive agents such as azathioprine and biologic agents such as infliximab 2, patients were diagnozed as mild-moderate CD 3, patients have other immune disordered diseases such as SLE, PBC, AIH, PSC, sjogren syndrome, ulcerative colitis, and so on.

结局指标

主要结局

single cell analysis of the colonic tissue of patients with severe crohn's disease

时间窗: 1 year

single cell analysis of the colonic tissue of patients with severe crohn's disease: inflammed and non-inflammed area from right colon or the terminal ileum

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验